Published in Open Forum Infect Dis on June 20, 2017
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS (2009) 16.37
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int (2011) 5.70
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med (2014) 4.91
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS (2002) 3.99
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health (2007) 3.69
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol (2012) 2.97
Epidemiology of cryptococcal meningitis in the US: 1997-2009. PLoS One (2013) 1.69
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis. J Infect (2011) 1.53
Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function. Am J Med (1972) 1.47
Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney Int (2005) 1.40
Urinary cystatin C as a specific marker of tubular dysfunction. Clin Chem Lab Med (2006) 1.31
Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf) (2013) 1.26
A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis. AIDS (2012) 1.19
Standardized electrolyte supplementation and fluid management improves survival during amphotericin therapy for cryptococcal meningitis in resource-limited settings. Open Forum Infect Dis (2014) 0.95
Biomarkers of impaired renal function. Curr Opin HIV AIDS (2010) 0.93
Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan. Antimicrob Agents Chemother (2012) 0.92
Role of new biomarkers: functional and structural damage. Crit Care Res Pract (2013) 0.90
Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study. Crit Care (2014) 0.86
Incidence and risk factors for acute kidney injury in HIV Infection. Am J Nephrol (2012) 0.82
Induction of interleukin-1beta, tumour necrosis factor-alpha and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan. J Antimicrob Chemother (2005) 0.81
From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injury. Clin Kidney J (2015) 0.80
Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transpl (2007) 0.80
Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies. Support Care Cancer (2005) 0.79
Sodium chloride treatment of amphotericin B nephrotoxicity. Standard of care? West J Med (1995) 0.78